$HRTX,Trading Scanner: Tracking Shares of Heron Therapeutics, Inc. (NASDAQ:HRTX)
February 13, 2017 Standard Staff Writer
Heron Therapeutics, Inc. presently has an ROIC of -4.339504. The current ROIC 5 year average is -4.306452 and the ROIC Quality ratio is currently -0.726204. ROIC is a metric that can be used to gauge the efficiency of a certain company at allocating controlled capital into investments that are profitable. ROIC has the ability to give a good sense of how a company is using its money to generate returns. ROIC may offer the clearest picture of just how efficient a company is at using its capital.
Heron Therapeutics, Inc. (NASDAQ:HRTX) has an EV (Enterprise Value) of 743267. EV represents the complete economic value of a given company. EV is considered to measure the theoretical takeover price if a company was to be acquired. EV takes into account more than just the outstanding equity. Debt and cash can have a big impact on a firm’s Enterprise Value. Although two companies may have a similar market cap, they may have widely different EV values. Heron Therapeutics, Inc. (NASDAQ:HRTX) currently has a Gross Margin (Marx) ratio of -0.599468. Robert Novy-Marx has provided investors with insights on finding high-quality value stocks. Marx pointed to a high gross income ratio defining the quality of a company. Heron Therapeutics, Inc. has a Gross Margin score of 41. The Gross Margin score lands between 1 and 100 where a score of 1 would be seen as good, and a score of 100 would be considered bad. This score is based on the Gross Margin stability and growth over the previous 8 years.
Value Investors may be looking to track the Magic Formula Rank or MF Rank for Heron Therapeutics, Inc. (NASDAQ:HRTX). After a recent check, Heron Therapeutics, Inc. has a MF Rank of 15895. The Magic Formula was developed by Joel Greenblatt in his publication “The Little Book That Beats the Market”. Greenblatt’s formula helps spot stocks that are priced attractively with a high earnings yield, or solid reported profits compared to the market value of the company. To identify opportunities in the equity market, investors may be checking for stocks that have the lowest combined MF Rank. {m:30|n:0|id:582|s:Name}} (NASDAQ:HRTX) has a present Value Composite Score of 92. This score lands on a scale from 0 to 100 where a lower score would indicate an undervalued company and a higher score would indicate an overvalued company. This ranking was created by James O’Shaughnessy using six different valuation ratios including price to book value, price to sales, EBITDA to EV, price to cash flow, price to earnings, and shareholder yield.
February 13, 2017 Standard Staff Writer
Heron Therapeutics, Inc. presently has an ROIC of -4.339504. The current ROIC 5 year average is -4.306452 and the ROIC Quality ratio is currently -0.726204. ROIC is a metric that can be used to gauge the efficiency of a certain company at allocating controlled capital into investments that are profitable. ROIC has the ability to give a good sense of how a company is using its money to generate returns. ROIC may offer the clearest picture of just how efficient a company is at using its capital.
Heron Therapeutics, Inc. (NASDAQ:HRTX) has an EV (Enterprise Value) of 743267. EV represents the complete economic value of a given company. EV is considered to measure the theoretical takeover price if a company was to be acquired. EV takes into account more than just the outstanding equity. Debt and cash can have a big impact on a firm’s Enterprise Value. Although two companies may have a similar market cap, they may have widely different EV values. Heron Therapeutics, Inc. (NASDAQ:HRTX) currently has a Gross Margin (Marx) ratio of -0.599468. Robert Novy-Marx has provided investors with insights on finding high-quality value stocks. Marx pointed to a high gross income ratio defining the quality of a company. Heron Therapeutics, Inc. has a Gross Margin score of 41. The Gross Margin score lands between 1 and 100 where a score of 1 would be seen as good, and a score of 100 would be considered bad. This score is based on the Gross Margin stability and growth over the previous 8 years.
Value Investors may be looking to track the Magic Formula Rank or MF Rank for Heron Therapeutics, Inc. (NASDAQ:HRTX). After a recent check, Heron Therapeutics, Inc. has a MF Rank of 15895. The Magic Formula was developed by Joel Greenblatt in his publication “The Little Book That Beats the Market”. Greenblatt’s formula helps spot stocks that are priced attractively with a high earnings yield, or solid reported profits compared to the market value of the company. To identify opportunities in the equity market, investors may be checking for stocks that have the lowest combined MF Rank. {m:30|n:0|id:582|s:Name}} (NASDAQ:HRTX) has a present Value Composite Score of 92. This score lands on a scale from 0 to 100 where a lower score would indicate an undervalued company and a higher score would indicate an overvalued company. This ranking was created by James O’Shaughnessy using six different valuation ratios including price to book value, price to sales, EBITDA to EV, price to cash flow, price to earnings, and shareholder yield.
I'm in it to win it!
NASDAQ DIP and RIP
Here is the best word that describes what i do here.
Intuitive;
means having the ability to understand or know something without any direct evidence or reasoning process.
I was born with it, I'm truly blessed!
Alway's searching for winners'
NASDAQ DIP and RIP
Here is the best word that describes what i do here.
Intuitive;
means having the ability to understand or know something without any direct evidence or reasoning process.
I was born with it, I'm truly blessed!
Alway's searching for winners'
